Basic Information
| RNALocate ID: | RLID:11002405 |
| RNA Symbol: | hsa-miR-30e-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-30e |
| RNA ID: | miRBase:MIMAT0000692 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23771658 |
| Tissue/Cell Line: | Hepatoma cells |
| Method: | Microarray|qRT-PCR |
| Description: | In line with the difference in number of detectable miRNAs, the expression levels of these miRNAs also varied between MVs and cells. Statistical analysis of the 148 co-expressing miRNAs showed that 25 miRNAs were aberrantly elevated inMVs and 75 miRNAs were significantly elevated in cells with more than two folds change. Forty-eight miRNAs had the similar signal intensity in both groups (table 1). Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002004 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002005 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002006 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11002395 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002396 | Exosome | Breast milk | 22211110 |
| RLID:11002397 | Exosome | Brain tissue | 23382797 |
| RLID:11002398 | Exosome | Plasma | 23663360 |
| RLID:11002399 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002400 | Exosome | Serum | 25349172 |
| RLID:11002401 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11002402 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002403 | Microvesicle | Plasma | 23077538 |
| RLID:11002404 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000115 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000404 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30e-5p | Diffuse large b cell lymphoma | MNDR-E-MI-37716 |
| MNDR | hsa-miR-30e-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37717 |
| MNDR | hsa-miR-30e-5p | Oral squamous cell carcinoma | MNDR-E-MI-37718 |
| MNDR | hsa-miR-30e-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-37719 |
| MNDR | hsa-miR-30e-5p | Lymphoma | MNDR-E-MI-37720 |
| MNDR | hsa-miR-30e-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-37721 |
| MNDR | hsa-miR-30e-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-37722 |
| MNDR | hsa-miR-30e-5p | Dermatomyositis | MNDR-E-MI-37723 |
| MNDR | hsa-miR-30e-5p | Prostate cancer | MNDR-E-MI-37724 |
| MNDR | hsa-miR-30e-5p | Gastric cancer | MNDR-E-MI-37725 |
| MNDR | hsa-miR-30e-5p | Alzheimer disease | MNDR-E-MI-37726 |
| MNDR | hsa-miR-30e-5p | Intracranial aneurysm | MNDR-E-MI-37727 |
| MNDR | hsa-miR-30e-5p | Bladder cancer | MNDR-E-MI-37728 |
| MNDR | hsa-miR-30e-5p | Esophageal carcinoma | MNDR-E-MI-37729 |
| MNDR | hsa-miR-30e-5p | Duchenne muscular dystrophy | MNDR-E-MI-37730 |
| MNDR | hsa-miR-30e-5p | Head and neck cancer | MNDR-E-MI-37731 |
| MNDR | hsa-miR-30e-5p | Leukemia | MNDR-E-MI-37732 |
| MNDR | hsa-miR-30e-5p | Huntington disease | MNDR-E-MI-37733 |
| MNDR | hsa-miR-30e-5p | Chorea | MNDR-E-MI-37734 |
| MNDR | hsa-miR-30e-5p | Cardiovascular disease | MNDR-E-MI-37735 |
| MNDR | hsa-miR-30e-5p | Moyamoya disease | MNDR-E-MI-37736 |
| MNDR | hsa-miR-30e-5p | Lung cancer | MNDR-E-MI-37737 |
| MNDR | hsa-miR-30e-5p | Down syndrome | MNDR-E-MI-37738 |
| MNDR | hsa-miR-30e-5p | Parkinson disease | MNDR-E-MI-37739 |
| MNDR | hsa-miR-30e-5p | Thyroid cancer | MNDR-E-MI-37740 |
| MNDR | hsa-miR-30e-5p | Pancreatic cancer | MNDR-E-MI-37741 |
| MNDR | hsa-miR-30e-5p | Melanoma | MNDR-E-MI-37742 |
| MNDR | hsa-miR-30e-5p | Rectum adenocarcinoma | MNDR-E-MI-37743 |
| MNDR | hsa-miR-30e-5p | Nephroblastoma | MNDR-E-MI-37744 |
| MNDR | hsa-miR-30e-5p | Colon cancer | MNDR-E-MI-37745 |
| MNDR | hsa-miR-30e-5p | Colon adenocarcinoma | MNDR-E-MI-37746 |
| MNDR | hsa-miR-30e-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37747 |
| MNDR | hsa-miR-30e-5p | Familial ovarian cancer | MNDR-E-MI-37748 |
| MNDR | hsa-miR-30e-5p | Prostate adenocarcinoma | MNDR-E-MI-37749 |
| MNDR | hsa-miR-30e-5p | Carcinoma ductal breast | MNDR-E-MI-37750 |
| MNDR | hsa-miR-30e-5p | Glioblastoma | MNDR-E-MI-37751 |
| MNDR | hsa-miR-30e-5p | Glioma | MNDR-E-MI-37752 |
| MNDR | hsa-miR-30e-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-37753 |
| MNDR | hsa-miR-30e-5p | Osteosarcoma | MNDR-E-MI-37754 |
| MNDR | hsa-miR-30e-5p | Liposarcoma | MNDR-E-MI-37755 |
| MNDR | hsa-miR-30e-5p | Inclusion body myositis | MNDR-E-MI-37756 |
| MNDR | hsa-miR-30e-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-37757 |
| MNDR | hsa-miR-30e-5p | Meningioma | MNDR-E-MI-37758 |
| MNDR | hsa-miR-30e-5p | Gastric adenocarcinoma | MNDR-E-MI-37759 |
| MNDR | hsa-miR-30e-5p | Lung squamous cell carcinoma | MNDR-E-MI-37760 |
| MNDR | hsa-miR-30e-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37761 |
| MNDR | hsa-miR-30e-5p | Lung adenocarcinoma | MNDR-E-MI-37762 |
| MNDR | hsa-miR-30e-5p | Adrenocortical cancer | MNDR-E-MI-37763 |
| MNDR | hsa-miR-30e-5p | Thyroid carcinoma | MNDR-E-MI-37764 |
| MNDR | hsa-miR-30e-5p | Bladder urothelial carcinoma | MNDR-E-MI-37765 |
| MNDR | hsa-miR-30e-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-37766 |
| MNDR | hsa-miR-30e-5p | Carcinoma renal cell | MNDR-E-MI-37767 |
| MNDR | hsa-miR-30e-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37768 |
| MNDR | hsa-miR-30e-5p | Large cell carcinoma | MNDR-E-MI-37769 |
| MNDR | hsa-miR-30e-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-37770 |
| MNDR | hsa-miR-30e-5p | Cholangiocarcinoma | MNDR-E-MI-37771 |
| MNDR | hsa-miR-30e-5p | Esophageal cancer | MNDR-E-MI-37772 |
| MNDR | hsa-miR-30e-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37773 |
| MNDR | hsa-miR-30e-5p | Testicular germ cell cancer | MNDR-E-MI-37774 |
| MNDR | hsa-miR-30e-5p | T acute lymphoblastic leukemia | MNDR-E-MI-37775 |
| MNDR | hsa-miR-30e-5p | Acute t cell leukemia | MNDR-E-MI-37776 |
| MNDR | hsa-miR-30e-5p | Acute heart failure | MNDR-E-MI-37777 |
| MNDR | hsa-miR-30e-5p | Breast invasive carcinoma | MNDR-E-MI-37778 |
| MNDR | hsa-miR-30e-5p | Hepatocellular carcinoma | MNDR-E-MI-37779 |
| MNDR | hsa-miR-30e-5p | Familiar ovarian carcinoma | MNDR-E-MI-37780 |
| MNDR | hsa-miR-30e-5p | B-cell lymphoma | MNDR-E-MI-37781 |
| MNDR | hsa-miR-30e-5p | Rheumatoid arthritis | MNDR-E-MI-37782 |
| MNDR | hsa-miR-30e-5p | Retinoblastoma | MNDR-E-MI-37783 |
| MNDR | hsa-miR-30e-5p | Hodgkin lymphoma | MNDR-E-MI-37784 |
| MNDR | hsa-miR-30e-5p | Burkitt lymphoma | MNDR-E-MI-37785 |
| MNDR | hsa-miR-30e-5p | Tonsil cancer | MNDR-E-MI-37786 |
| MNDR | hsa-miR-30e-5p | Psoriasis | MNDR-E-MI-37787 |
| MNDR | hsa-miR-30e-5p | Skin cutaneous melanoma | MNDR-E-MI-37788 |
| MNDR | hsa-miR-30e-5p | Skin melanoma | MNDR-E-MI-37789 |
| MNDR | hsa-miR-30e-5p | Acute myelocytic leukemia | MNDR-E-MI-37790 |
| MNDR | hsa-miR-30e-5p | Colorectal cancer | MNDR-E-MI-37791 |
| MNDR | hsa-miR-30e-5p | Nasopharynx carcinoma | MNDR-E-MI-37792 |
| MNDR | hsa-miR-30e-5p | Acute lymphocytic leukemia | MNDR-E-MI-37793 |
| MNDR | hsa-miR-30e-5p | Cardiomegaly | MNDR-E-MI-37794 |
| MNDR | hsa-miR-30e-5p | Nasopharyngeal cancer | MNDR-E-MI-37795 |
| MNDR | hsa-miR-30e-5p | Sleep deprivation | MNDR-E-MI-37796 |
| MNDR | hsa-miR-30e-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37797 |
| MNDR | hsa-miR-30e-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37798 |
| MNDR | hsa-miR-30e-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37799 |
| MNDR | hsa-miR-30e-5p | Stroke lacunar | MNDR-E-MI-37800 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AC254633.1 | Homo sapiens | RR00032114 |
TOP